financetom
Business
financetom
/
Business
/
Host Hotels & Resorts beats Q1 estimates on higher business travel demand
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Host Hotels & Resorts beats Q1 estimates on higher business travel demand
May 1, 2024 2:42 PM

May 1 (Reuters) - Host Hotels & Resorts ( HST ) raised

its 2024 per share forecast for funds from operations on

Wednesday, as business travel demand continues to recover.

U.S. travel companies have been benefiting from increased

business demand from large enterprises, whose bookings for group

travel sometimes exceed 300 rooms per trip.

Host, which has a portfolio that includes hotels such as

Hyatt and Marriott's Ritz Carlton, now expects full-year

adjusted funds from operations between $1.97 and $2.05 per

share, compared with $1.92 to $2.04 per share expected

previously.

The Bethesda, Maryland-based real estate investment trust

reported first-quarter adjusted FFO per share - a key metric

that measures a REIT's cash flow - of 60 cents. Analysts on

average were expecting adjusted FFO of 55 cents per share,

according to LSEG data.

"Banquet revenues led our performance, driven by

improvements in group business and continued strong demand in

food and beverage," CEO James Risoleo said.

The company reported first-quarter revenue of $1.47 billion,

up 6.5% from last year and above analysts' estimate of $1.42

billion, according to LSEG data.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Novo Nordisk braces for generic challenge to Ozempic, Wegovy in China
Novo Nordisk braces for generic challenge to Ozempic, Wegovy in China
Jun 5, 2024
SHANGHAI (Reuters) -Novo Nordisk is facing the prospect of intensifying competition in the promising Chinese market where drugmakers are developing at least 15 generic versions of its diabetes drug Ozempic and weight loss treatment Wegovy, clinical trial records showed. The Danish drugmaker has high hopes that demand for its blockbuster drugs will surge in China, which is estimated to have...
FOCUS-Novo Nordisk braces for generic challenge to Ozempic, Wegovy in China
FOCUS-Novo Nordisk braces for generic challenge to Ozempic, Wegovy in China
Jun 5, 2024
SHANGHAI, June 6 (Reuters) - Novo Nordisk is facing the prospect of intensifying competition in the promising Chinese market where drugmakers are developing at least 15 generic versions of its diabetes drug Ozempic and weight loss treatment Wegovy, clinical trial records showed. The Danish drugmaker has high hopes that demand for its blockbuster drugs will surge in China, which is...
Meta gets 11 EU complaints over use of personal data to train AI models
Meta gets 11 EU complaints over use of personal data to train AI models
Jun 5, 2024
BRUSSELS (Reuters) - Meta Platforms ( META ) was hit with 11 complaints on Thursday over proposed changes that would see it use personal data to train its artificial intelligence models without asking for consent, which may breach European Union privacy rules. Advocacy group NOYB (none of your business) urged national privacy watchdogs to act immediately to halt such use,...
KKR, GIP lead $25 billion regional infrastructure tie-up, US says
KKR, GIP lead $25 billion regional infrastructure tie-up, US says
Jun 5, 2024
SINGAPORE, June 6 (Reuters) - KKR, Global Infrastructure Partners (GIP) and the Indo-Pacific Partnership for Prosperity have formed a coalition to invest $25 billion in infrastructure in the Indo-Pacific region, U.S. Commerce Secretary Gina Raimondo said on Thursday. Raimondo, speaking in Singapore, said investment would include green data centres in Indonesia, renewable energy in the Philippines and smart metres and...
Copyright 2023-2026 - www.financetom.com All Rights Reserved